Pulmonology Articles

Pulmonology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Sasaki T et al. - In this single-blind, nonplacebo-controlled trial, lansoprazole was associated with a significant decrease in COPD exacerbations. More definitive clinical trials are warranted.

Related Articles

Molecular mechanism and functional consequences of lansoprazole-mediated heme oxygenase-1 induction
World Journal of Gastroenterology, 10/06/09    Relevance Score: 87%

Delayed release dexlansoprazole in the treatment of GERD and erosive esophagitis
Clinical and Experimental Gastroenterology, 11/17/09    Relevance Score: 80%

Mylan Receives FDA Approval for Generic Version of Prevacid Through its Subsidiary Matrix Laboratories
Mylan, 11/11/09    Relevance Score: 80%

Acute Kidney Injury in Patients with Inactive Cytochrome P450 Polymorphisms
Renal Failure, 10/30/09    Relevance Score: 80%

Safety profile of dexlansoprazole MR, a proton pump inhibitor with a novel dual delayed release formulation: global clinical trial experience
Alimentary Pharmacology and Therapeutics, 10/23/09    Relevance Score: 80%

Today in COPD...keeping you current

Airway appliances in endoscopy
Techniques in Gastrointestinal Endoscopy , 12/17/09

Survival impact of lung transplantation for chronic obstructive pulmonary disease
European Respiratory Journal , 12/17/09

The 15q24/25 Susceptibility Variant for Lung Cancer and COPD is Associated with Emphysema
American Journal of Respiratory and Critical Care Medicine, 12/17/09

Today in Clinical Pharmacology...keeping you current

Taurolidine in the prevention and therapy of lung metastases
European Journal of Cardio-Thoracic Surgery, 12/17/09

Community-acquired upper respiratory tract infections and the role of third-generation oral cephalosporins
Expert Review of Anti-infective Therapy, 12/17/09

Oral Immunotherapy with inactivated NTHi reduces severity of acute exacerbations in severe COPD
Chest, 12/16/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address